Comparison of four methods for DNA typing of clinical isolates of Candida glabrata

Journal of Medical Microbiology

Volumn 48, Issue 10, 1999, Pages 955-963

  Di Francesco, Luigi Falconi ^a   Barchiesi, Francesco ^a   Caselli, Francesca ^a   Cirioni, Oscar ^a   Scalise, Giorgio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL DNA;

ARTICLE; CANDIDA GLABRATA; CLINICAL ARTICLE; DNA DETERMINATION; HUMAN; KARYOTYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0032741724     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-10-955     Document Type: Article

References (17)

1. Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992; 14 Suppl 1: S43-S53.
2. Cormican MG, Hollis RJ, Pfaller MA. DNA macrorestriction profiles and antifungal susceptibility of Candida (Torulopsis) glabrata. Diagn Microbiol Infect Dis 1996; 25: 83-87.
3. Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient. Frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989; 11: 379-390.
4. Lehmann PF, Lin D, Lasker BA. Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA. J Clin Microbiol 1992; 30: 3249-3254.
5. Pfaller MA, Rhine-Chalberg J, Redding SW et al. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol 1994; 32: 59-64.
6. Scherer S, Stevens DA. Application of DNA typing methods to epidemiology and taxonomy of Candida species, J Clin Microbiol 1987; 25: 675-679.
7. Scherer S, Stevens DA. A Candida albicans dispersed repeated gene Family and its epidemiologic applications. Proc Natl Acad Sci USA 1988; 85: 1452-1456.
8. Schmid J, Odds FC, Wiselka MJ, Nicholson KG, Soll DR. Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting. J Clin Microbiol 1992; 30: 935-941.
9. van Belkum A, Melchers W, de Pauw BE, Scherer S, Quint W, Meis JF. Genotypic characterization of sequential Candida albicans Isolates from fluconazole-treated neutropenic patients. J Infect Dis 1994; 169: 1062-1070.
10. Arif S, Barkham T, Power EG, Howell SA. Techniques for investigation of an apparent outbreak of infections with Candida glabrata. J Clin Microbiol 1996; 34: 2205-2209.
11. Khattak MN, Burnie JP, Matthews RC, Oppenheim BA. Clamped homogeneous electric field gel electrophoresis typing of Torulopsis glabrata isolates causing nosocomial infections. J Clin Microbiol 1992; 30: 2211-2215.
12. Lockhart SR, Joly S, Pujol C, Sobel JD, Pfaller MA, Soll DR. Development and verification of fingerprinting probes for Candida glabrata, Microbiology 1997; 143: 3733-3746.
13. Vazquez JA, Beckley A, Donabedian S, Sobel JD, Zervos MJ. Comparison of restriction enzyme analysis versus pulsed-field gradient gel electrophoresis as a typing system for Torulopsis glabrata and Candida species other than C. albicans. J Clin Microbiol 1993; 31: 2021-2030.
14. Barchiesi F, Arzeni D, Del Prete MS et al. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis. J Antimicrob Chemother 1998; 41: 541-548.
15. Romesburg HC. Cluster analysis for researchers. Malabar, FL. Robert E Krieger 1990.
16. Asakura K, Iwaguchi S-I, Homma M, Sukai T, Higashide K, Tanaka K. Electrophoretic karyotypes of clinically isolated yeasts of Candida albicans and C. glabrata. J Gen Microbiol 1991; 137: 2531-2538.
17. Pfaller MA. Epidemiology and control of fungal infections. Clin infect Dis 1994; 19 Suppl 1: S8-S13.